ArticleJournal of invertebrate pathology2026
The potential of Clonostachys rosea as a biolarvicide against Anopheles gambiae.
Article in Journal of invertebrate pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update ofThe potential of2025
Authors and funding
5 authors.
Funding
Abstract
Mosquitoes vector multiple disease-causing pathogens detrimental to humans, imposing a high public health and economic burden. Chemical and biological larvicides are used in some settings to reduce mosquito populations as a supplement to adult population control. In this study, we assessed the larvicidal potential of a newly isolated strain of the hypocrealean fungus, Clonostachys rosea, by modifying a previously established laboratory-based experimental design. This design allowed us to distinguish between the larvicidal impact of the fungal culture supernatant and conidia. Our data show that C. rosea efficiently kills larvae of the African malaria mosquito, Anopheles gambiae, at an LC50 of 7.78 × 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.